Departamento académico
(FM) Inmunología
Argitalpenak (17) Ikertzaileren baten partaidetza izan duten argitalpenak
2007
-
A network analysis of the human T-cell activation gene network identifies Jagged1 as a therapeutic target for autoimmune diseases
PLoS ONE, Vol. 2, Núm. 11
-
Absence of surface expression of CD137 (4-1BB) on Myeloid-derived suppressor cells
Inmunologia, Vol. 26, Núm. 3, pp. 121-126
-
Anti-idiotype antibodies in cancer treatment
Oncogene, Vol. 26, Núm. 25, pp. 3594-3602
-
Antitumor T-cell wars: Do CD4s outwit CD8s?
Blood
-
BY55/CD160 cannot be considered a cytotoxic marker in cytomegalovirus- specific human CD8+ T cells
Clinical and Experimental Immunology, Vol. 149, Núm. 1, pp. 87-96
-
Cellular liaisons of natural killer lymphocytes in immunology and immunotherapy of cancer
Expert Opinion on Biological Therapy, Vol. 7, Núm. 5, pp. 599-615
-
Human follicular lymphoma cells contain oligomannose glycans in the antigen-binding site of the B-cell receptor
Journal of Biological Chemistry, Vol. 282, Núm. 10, pp. 7405-7415
-
Imiquimod enhances the systemic immunity attained by local cryosurgery destruction of melanoma lesions
Journal of Investigative Dermatology, Vol. 127, Núm. 7, pp. 1673-1680
-
Immunostimulatory monoclonal antibodies for cancer therapy
Nature Reviews Cancer, Vol. 7, Núm. 2, pp. 95-106
-
Immunotherapy and immunoescape in colorectal cancer
World Journal of Gastroenterology, Vol. 13, Núm. 44, pp. 5822-5831
-
In vitro and in vivo arterial differentiation of human multipotent adult progenitor cells
Blood, Vol. 109, Núm. 6, pp. 2634-2642
-
La terapia celular antitumoral
Gastroenterologia y Hepatologia Continuada
-
Multipotent Adult Progenitor Cells (MAPC) contribute to hepatocarcinoma neovasculature
Biochemical and Biophysical Research Communications, Vol. 364, Núm. 1, pp. 92-99
-
Nuevos tratamientos para el carcinoma renal
Anales del sistema sanitario de Navarra, Vol. 30, Núm. 3, pp. 393-403
-
Parvovirus B19 acute infection and a reactivation of cytomegalovirus and herpesvirus 6 in a chronic myeloid leukemia patient during treatment with dasatinib (BMS-354825)
Leukemia and Lymphoma, Vol. 48, Núm. 12, pp. 2461-2464
-
The combined actions of NK and T lymphocytes are necessary to reject an EGFP+ mesenchymal tumor through mechanisms dependent on NKG2D and IFNγ
International Journal of Cancer, Vol. 121, Núm. 6, pp. 1282-1295
-
The many faces of regulatory T cells
Inmunologia, Vol. 26, Núm. 1, pp. 29-41